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OBJECTIVE—To perform the ﬁrst comprehensive psychometric evaluation of the Hypogly-
cemia Fear Survey-II (HFS-II), a measure of the behavioral and affective dimensions of fear of
hypoglycemia, using modern test-theory methods, including item-response theory (IRT).
RESEARCH DESIGN AND METHODS—Surveys completed in four previousstudies by
777 adults with type 1 diabetes were aggregated for analysis, with 289 subjects completing both
subscales of the HFS-II and 488 subjects completing only the Worry subscale. The aggregated
sample (53.3% female, 44.4% using insulin pumps) had a mean age of 41.9 years, diabetes
duration of 23.8 years, HbA1c value of 7.7%, and 1.4 severe hypoglycemic episodes in the past
year. Data analysis included exploratory factor analysis using polychoric correlations and IRT.
Factors were analyzed for ﬁt, trait-level locations, point-measure correlations, and separation
values.
RESULTS—Internal and test-retest reliability was good, as well as convergent validity, as
demonstrated by signiﬁcant correlations with other measures of psychological distress. Scores
were signiﬁcantly higher in subjects who had experienced severe hypoglycemia in the past year.
Factor analyses validated the two subscales of the HFS-II. Item analyses showed that 12 of 15
items on the Behavior subscale, and allof the items on the Worry subscale had good-ﬁt statistics.
CONCLUSIONS—The HFS-II is a reliable and valid measure of the fear of hypoglycemia in
adultswithtype1diabetes,andfactoranalysesandIRTsupportthetwoseparatesubscalesofthe
survey.
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T
he Hypoglycemia Fear Survey
(HFS), ﬁrst published in 1987 (1),
originally was developed to measure
behaviors and worries related to fear of
hypoglycemia (FOH) in adults with type
1 diabetes. Both the original HFS (HFS-I)
and the revised version (HFS-II) are com-
posed of two subscales, the Behavior
(HFS-B) and Worry (HFS-W). HFS-B
items describe behaviors in which pa-
tients may engage to avoid hypoglycemic
episodes and/or their negative conse-
quences (e.g., keeping blood glucose
[BG] levels above 150 mg/dL, making
sure other people are around, and limit-
ing exercise or physical activity). HFS-W
items describe speciﬁc concerns that pa-
tientsmay have abouttheirhypoglycemic
episodes (e.g., being alone, episodes oc-
curring during sleep, or having an acci-
dent). Since it was ﬁrst published, the
HFS, in its original form and subsequent
revisions, has been used in .60 pub-
lishedstudiesandnumerousclinicaltrials
and has been translated into over 50 lan-
guages. The survey also is commonly
used in studies of people with type 2 di-
abetes to better understand their experi-
ences of hypoglycemia (2). In addition,
the authors have developed alternative
versions of the HFS for use with pediatric
patients with type 1 diabetes and their
parents, as well as spouses and signiﬁcant
others of adults with diabetes (3–5).
Despite its widespread use, the only
comprehensive study to address the psy-
chometric properties of the U.S. HFS was
published .15 years ago and focused on
the HFS-I, which is no longer in use (6).
Since then, based on subsequent studies,
the scale has been signiﬁcantly revised,
leaving only 18 of 33 items unchanged
from the original version from 1987. Al-
though there is some evidence for the re-
liability and validity of the HFS-II (2,7),
no comprehensive study of its psycho-
metric properties has been conducted
with a large sample. In addition, psycho-
metric results of previous studies included
only classical test-theory methods that
have not acknowledged thecategoricalna-
ture of HFS data. Modern test procedures,
suchasitem-responsetheory(IRT),arebet-
ter suited to analyze categorical data and
can provide valuable information about
item quality, including response option
use, ﬁt, and endorsement difﬁculty (8).
For researchers and clinicians inter-
ested in using the HFS-II, this lack of
supporting psychometric data presents
many obstacles not the least of which is
the inability to interpret scores in a clin-
ically meaningful way. The purpose of the
current study was to conduct a compre-
hensive psychometric investigation of the
HFS-II U.S. English adult version using a
large aggregate sample of data collected at
our laboratory over the past decade and
using modern test-theory methods. The
following were the hypotheses tested:
1) that the HFS-II is a reliable and valid
measure of FOH and 2) that factor anal-
ysis will yield a two-factor structure re-
ﬂecting the two subscales of the survey.
RESEARCH DESIGN AND
METHODS—This was a secondary
data analysis study using HFS-II survey
data collected from four different Na-
tional Institutes of Health–funded proj-
ects conducted at the University of
Virginia Center for Behavioral Medicine
Researchbetween1998and2009.Details
of the methods for several of these proj-
ects have been previously published
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ORIGINAL ARTICLE(9,10). All four projects included partici-
pants who had type 1 diabetes for at least
1 year and were willing to perform BG
measurements at least two times every
day. Study 1 had an additional inclusion
criterion of having a history of two or
more episodes of severe hypoglycemia
during the past year. Study 4, a survey
of drivers with diabetes, had additional
criteria of possessing a legal driver’s li-
cense and driving at least 10,000 miles
per year. In each study, participants
completed a battery of questionnaires, in-
cludingtheHFS-II.Althoughstudies1,2,
and 3 included the entire HFS-II scale
(i.e., both HFS-B and HFS-W subscales),
study 4 only used the HFS-W subscale.
Participants in all studies also completed
a diabetes history questionnaire, includ-
ing an item to assess frequency of severe
hypoglycemia over the past year. Severe
hypoglycemia was deﬁned as a hypogly-
cemic episode during which BG was so
low that self-treatment was not possible
because of mental confusion or stupor
and external assistance was required.
Glycosylated hemoglobin (HbA1c) mea-
sures were available for three studies.
Finally, all four studies included addi-
tional psychological questionnaires, in-
cluding the Beck Depression Inventory
(11), the Beck Anxiety Inventory (12),
the Modiﬁed State-Trait Personality In-
ventory (13), and the Short-Form (SF)
12 Quality-of-Life Inventory (14). These
measures were used to assess the con-
struct validity of the HFS-II. Only base-
line data (i.e., before any intervention)
wasincludedforthepurposesofthecur-
rent study.
Sample characteristics
The total number of participants with
HFS-II data was 777, with 289 partici-
pants completing the HFS-B subscale and
488 participants completing only the
HFS-Wsubscale.Acrossthestudies,there
were no differences in sex composition,
mean HbA1c values, mean age, or ethnic-
ity.Thereweredifferencesinmeanduration
ofdiabetes[F(3,791)=10.22,P,0.0005;
minimum–maximum = 19.6–26.0 years]
and years of education [F(2,661) = 10.9,
P ,0.0005; minimum–maximum= 14.9–
15.9 years], but these did not appear to be
clinically meaningful. For the aggregate
sample, mean (SD) age was 41.9 (12.6)
years, diabetes duration was 23.8 (12.5)
years, HbA1c was 7.7 (1.4) %, and educa-
tionwas15.6(2.5)years.A totalof53.3%
of the subjects were female, 44.4% used
insulin pumps, 63.1% reported no severe
hypoglycemia in the past year, and 95.9%
were white.
Data analysis
Descriptive statistical analyses, correla-
tions, group comparisons, and Cronbach
areliabilityanalyseswereperformedwith
PASW 18.0.2 (SPSS, Chicago, IL). Be-
cause factor analyses have not previously
been conducted on the HFS-II, the di-
mensional structure of the survey was ex-
aminedwithexploratoryfactoranalysisin
Mplus software (15), using polychoric
correlations for handling the categorical
natureofthedata.Modelﬁtwasestimated
using a x
2 goodness-of-ﬁt statistic, root
mean squared error of approximation
(RMSEA), standardized root mean
squared residuals (SRMRs), and the
Tucker-Lewis Index (TLI). Currently,
there is much debate in the ﬁeld about
cutoffs for ﬁt indices (16), but, in general,
RMSEA and SRMR values ,0.10 indicate
acceptable ﬁt (17,18) and TLI values
.0.90 indicate acceptable ﬁt( 1 9 ) .
IRT methods were used to assess the
rating scale of HFS-II items. HFS-B and
HFS-Wsubscaleswereanalyzedusingthe
Rasch Partial Credit Model (PCM) in
Winsteps (20). Several statistics from
PCM analyses assess item quality and re-
sponses. These include 1)i n ﬁta n do u t ﬁt
statistics that indicate the degree of ﬁtb e -
tween item endorsement scores and the
person’s level of the trait being measured,
in this case FOH; 2) point-measure corre-
lations, which are similar to item-total
correlations, with a range of 21t o1o n
thePCMlogitscale(lowandnegativevalues
being problematic); and 3) separation
values that indicate the degree of distin-
guishable trait levels measured by the
scale, with high values desirable (e.g., a
separation of “2” indicates that only two
levels of the trait are distinguishable and a
separation of “3” indicates three levels,
etc). Separation is computed as the ratio
of the test SD corrected for estimation
error to root mean squared error (RMSE).
RESULTS
Mean HFS scores
Table 1 summarizes the mean total HFS-
I I ,H F S - B ,a n dH F S - Ws c o r e sf o re a c h
study and for the aggregate sample.
Scores were signiﬁcantly higher on the
total HFS-II and HFS-W in study 1, in
which inclusion criteria required that in-
dividuals had experienced two or more
episodes of severe hypoglycemia in the
previous year compared with other stud-
ies {F(2,282) = 8.46, P , 0.0005
(T12[143.4] = 2.43, P = 0.016,
T13[128.3] = 3.83, P , 0.0005) and
F(3,773) = 26.47, P , 0.0005
(T12[152.1] = 3.84, P , 0.0005,
T13[141.5] = 5.40, P , 0.0001,
T14[174.3] = 7.27, P , 0.0001), respec-
tively}. There were no differences in HFS-
B(Mi=18.0,SD=9.4;Mp=17.3.SD=9.2)
or HFS-W scores (Mi = 22.1, SD = 14.6;
Mp = 22.1, SD = 13.9) as a result of in-
sulin regimen (injection versus pump)
[F(1,259) = 0.32, P =0 . 5 7 2a n dF(1,747) =
0.00, P = 0.951, respectively]. HFS-B
scores were signiﬁcantly higher for female
subjects (M=19.0, SD=9.8)thanformale
subjects (M=16.8, SD = 8.5) [F(1,281) =
4.07,P =0.045].HFS-Wscoreswerealso
signiﬁcantly higher for female subjects
(M=23.4,SD=14.5)thanformalesubjects
(M=21.0, SD = 14.0) [F(1,773) = 5.395,
P = 0.02]. Years of education were nega-
tively correlated with HFS-B (r = 20.28,
Table 1—HFS-II score means (SD) by study
Score All studies Study 1 Study 2 Study 3 Study 4
n 777* 80 96 113 488
HFS-II
Total 44.1 (21.7) 52.2 (24.8) 43.5 (20.6) 39.3 (18.7)
Item 1.3 (0.7) 1.6 (0.8)a,b 1.3 (0.6)a 1.2 (0.6)b
HSB-B
Total 17.9 (9.3) 18.8 (10.5) 18.1 (9.6) 17.2 (8.1)
Item 1.2 (0.6) 1.3 (0.7) 1.2 (0.6) 1.2 (0.5)
HSB-W
Total 22.3 (14.4) 34.0 (16.6) 25.2 (13.5) 22.1 (12.7) 19.9 (13.4)
Item 1.2 (0.8) 1.9 (0.9)a,b,c 1.4 (0.8)a,e 1.2 (0.7)b 1.1 (0.8)c,e
Means sharing the same subscript denote statistically signiﬁcant differences; all P , 0.0169 for total HFS-II
comparisons and P , 0.0085 for HFS-W comparisons. *Total n for total HFS-II and HFS-B is 279 and 289,
respectively.
802 DIABETES CARE, VOLUME 34, APRIL 2011 care.diabetesjournals.org
Hypoglycemia Fear Survey-IIP=0.0001)andHFS-Wscores(r=20.10,
P=0.016).HFS-IIscoresdid notcorrelate
with age or duration of diabetes.
Reliability analyses
Cronbach a coefﬁcients indicated a high
level of internal consistency for the total
HFS-II (a = 0.94), HFS-B (a = 0.85), and
HFS-W(a=0.94)scores.Test–retestdata
were available from one study (study 3)
that usedarepeated-baseline design,with
2 months between data collection. Tem-
poral reliability was 0.74 for the total
HFS-II, 0.81 for the HFS-B, and 0.63 for
the HFS-W scales.
Validity analyses
As Table 2 shows, both the HFS-B and
HFS-W correlated positively with mea-
sures of psychological distress, including
the Modiﬁed State-Trait Personality In-
ventory Anxiety, Anger, and Depression
Subscales, as well as the Beck Depression
Inventory and Beck Anxiety Inventory.
HFS-B and HFS-W scores correlated neg-
atively with health-related quality of life,
including the SF-12 Physical and Mental
scores.
Table 2 also shows that both HFS-B
and HFS-W scores were signiﬁcantly
higher for those who had experienced
severehypoglycemiainthepastyearcom-
paredwiththosewhohadnot[F(1,281)=
8.956, P = 0.003 and F(1,770) = 63.037,
P , 0.0005, respectively], with effect
sizes 0.35 for the HFS-B and 0.58 for
the HFS-W. Median HFS-B item scores
were 1.27 for those who experienced SH
and 1.0 for those who did not experience
SH,withinterquartilerangescoresof0.87
and 0.63, respectively. Median HFS-W
item scores were 1.44 for those with a
history severe hypoglycemia and 0.94
for those with no history in the past
year, with interquartile range scores of
1.13 and 0.89, respectively. HFS-B scores
were higher for those with HbA1c $7.5%
compared with those with HbA1c ,7.5%
[F(1,268) = 5.34, P = 0.022], with an ef-
fect size of 0.28. HFS-W scores did not
differ, with an effect size of 0.12. Median
HFS-B scores were 1.13 for those with
HbA1c $7.5% and 1.0 for those with
HbA1c ,7.5%, with interquartile range
scores of 0.87 and 0.73, respectively.
Factor analyses
T a b l e3s u m m a r i z e sf a c t o ra n a l y s e sr e -
sults. Fit estimates for the one-factor so-
lution were questionably acceptable
[x
2(79) = 1,288.4, P , 0.0001; RMSEA =
0.14, SRMR = 0.13, TLI = 0.92] but
improved in the two-factor solution
[x
2(102) = 973.8, P , 0.0001; RMSEA =
0.10, SRMR = 0.08, TLI = 0.95]. As ex-
pected, this two-factor solution reﬂected
the two HFS-II subscales. The Dx
2(23) =
314.6 between these two models in-
dicates that the two-factor solution ﬁt
better. A three-factor model also was
tested and ﬁtt h ed a t a[ x
2(112) = 630.1,
P , 0.0001; RMSEA = 0.08, SRMR =
0.06, TLI = 0.98], with only four HFS-B
itemsloadingontoathirdfactor.Basedon
study hypotheses and the ﬁto ft h et w o -
factor solution reﬂecting the HFS-II sub-
scales, IRT analysis was performed on the
two-factor solution.
In the two-factor solution, 13 of 15
HFS-B items loaded onto the ﬁrst factor,
with coefﬁcients ranging from 0.33 to
0.87(seeTable3).Theonlyitemsthatdid
n o tl o a dw i t h i nt h i st w o - f a c t o rs o l u t i o n
range were HFS-B3 and HFS-B4. All 18
HFS-W items loaded ontothe second fac-
tor,with coefﬁcientsranging from0.43to
1.04. The correlation between these two
subscales was r =0 . 6 0( P , 0.0005).
These results support two distinct, yet
correlated, dimensions of FOH.
IRT analyses
Optimal assessment is indicated by
matching between person trait-level
scores and item endorsement scores.
Nearly all item endorsement scores
m a t c h e dw i t hi n d i v i d u a lp e r s o nt r a i t
scores within the range of the highest to
lowest scores for both people and items.
The following scores are reported in
logits. For HFS-B item endorsement
scores, M =0 . 0 0( b yd e ﬁnition) and
SD=0.58andforpersonHFS-Btrait-level
scores,M=20.86,SD=0.83.ForHFS-W
item endorsement scores, M =0 . 0 0( b y
deﬁnition) and SD = 0.44 and for person
HFS-W trait-level scores, M = 21.01 and
SD = 1.26. For both scales, the mean per-
son trait-level score was slightly lower
than mean item endorsement score, and
person trait-level variability was greater
than item variability for the respective
scales, which was acceptable. Items were
rank-ordered separately for each subscale
from the most frequently strongly en-
dorsed item to the least frequently
strongly endorsed item, on average (see
Table 3).
HFS-B subscale
Twelve HFS-B items showed excellent ﬁt
(item responses were as expected), with
proper ranges of inﬁt values (0.64–1.28)
Table 2—Correlations and mean (SD) HFS-II scores by measures of validity
Correlations HFS-B HFS-W Total HFS
n 283 777 279
Beck Depression Inventory 0.35* 0.45* 0.43*
Beck Anxiety Inventory 0.51* 0.55* 0.61*
Modiﬁed State-Trait Personality Inventory
Anxiety 0.30* 0.38* 0.39*
Depression 0.26† 0.29* 0.31*
Anger 0.21‡ 0.22‡ 0.24‡
SF-12
Physical 20.42* 20.26‡ 20.32†
Mental 20.41* 20.63* 20.58*
History of severe hypoglycemia
In the past year
Total 19.9 (10.2)* 27.5 (15.4)† 49.6 (23.2)†
Item 1.3 (0.7) 1.5 (0.9) 1.5 (0.7)
Not in the past year
Total 16.6 (8.3) 19.3 (12.8) 40.1 (19.7)
Item 1.1 (0.6) 1.1 (0.7) 1.2 (0.6)
Glycosylated hemoglobin (%)
,7.5
Total 16.6 (9.4)‡ 25.7 (15.5) 42.1 (21.8)
Item 1.1 (0.6) 1.4 (0.9) 1.3 (0.7)
$7.5
Total 19.2 (9.1) 27.5 (14.5) 46.3 (21.7)
Item 1.3 (0.6) 1.5 (0.8) 1.4 (0.7)
*P , 0.001; †P , 0.01; ‡P , 0.05.
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Gonder-Frederick and Associatesand outﬁt values (0.67–1.09). Point-
measure correlations for these items
ranged from 0.40 to 0.72, which is excel-
lent. For HFS-B3 and HFS-B4, inﬁta n d
outﬁt values indicated less ﬁtt h a ne x -
pected, had low point-measure correla-
tions, and were the two most frequently
strongly endorsed items, on average. For
HFS-B8, outﬁt was better than expected,
and it was the least frequently strongly en-
dorsed item with lower variability com-
pared with other HFS-B items. Separation
for the HFS-B was 7.92, indicating nearly
eightstatisticallydistinguishabletraitlevels
and excellent discrimination quality.
HFS-W subscale
Seventeen HFS-W items showed excel-
lent ﬁt, with ranges of inﬁt values (0.77–
1.25) and outﬁt values (0.72–1.27).
Point-measure correlations ranged from
0.49 to 0.74. HFS-W2 had the highest
outﬁta n di n ﬁt values. No other statistics
(item endorsement score, point-measure
correlation) were extreme, so concern
for this item was negligible. Separation
for the HFS-W was 9.35, indicating over
nine statistically distinguishable trait
levels and excellent discrimination qual-
ity. See Table 3 for item endorsement
score level rankings.
CONCLUSIONS—The survey dem-
onstrated strong internal consistency,
with reliability coefﬁcients $0.85 for the
total HFS-II and subscales. Temporal re-
liability was adequate, ranging from 0.81
(HFS-B) to 0.63 (HFS-W), although it is
important tonote that FOH would not be
expected to stay completely stable over
time. Previous studies have shown that
levels of FOH can increase after traumatic
experiences with severe hypoglycemia
(21) and decrease after interventions
that reduce the frequency of hypoglyce-
mia (22,23).
Several ﬁndings support the validity
of the HFS-II, including signiﬁcantly
higher scores for both subscales in pa-
tient populations expected to have higher
levels of FOH, such as those who expe-
rience more frequent severe hypoglyce-
mia. In addition, HFS-B scores, but not
HFS-W scores, were higher in patients
with poorer glycemic control, indicative
of more hyperglycemia. Female subjects
also had signiﬁcantly higher HFS-II
scores, replicating numerous studies that
found higher levels of emotional and
physical symptoms in female subjects
Table 3—Exploratory factor analysis results
Item Item content
One-factor solution Two-factor solution
PCM ranking* Factor 1 Factor 1 Factor 2
HFS-B1 Ate large snack 0.24 0.33 20.02 B-3
HFS-B2 Kept BG .150 mmol/L 0.4 0.42 0.07 B-6
HFS-B3 Reduced insulin when BG low 0.12 0.04 0.1 B-1
HFS-B4 Measured BG six or more times per day 0.09 0.2 20.08 B-2
HFS-B5 Take someone with me when out 0.58 0.76 20.09 B-7
HFS-B6 Limited out-of-town travel 0.78 0.85 0.01 B-10
HFS-B7 Limited driving 0.68 0.72 0.06 B-9
HFS-B8 Avoided visiting friends 0.86 0.86 0.11 B-14
HFS-B9 Stayed home more than liked 0.79 0.81 0.08 B-11
HFS-B10 Limited physical activity 0.56 0.67 0 B-8†
HFS-B11 Made sure others were around 0.69 0.81 20.01 B-8†
HFS-B12 Avoided sex 0.52 0.56 0.06 B-12
HFS-B13 Kept BG high in social situations 0.64 0.87 20.13 B-5
HFS-B14 Kept BG high during important tasks 0.65 0.84 20.08 B-4
HFS-B15 Had others check on me 0.59 0.67 0.04 B-13
HFS-W1 Not recognizing low BG 0.65 0.16 0.57 W-2
HFS-W2 Not having food available 0.43 0.04 0.43 W-5
HFS-W3 Passing out in public 0.76 0.13 0.7 W-17
HFS-W4 Embarrassing myself in social situation 0.75 0.24 0.61 W-14
HFS-W5 Having hypoglycemic episode alone 0.81 0.32 0.61 W-4
HFS-W6 Appearing drunk or stupid 0.79 0.25 0.64 W-15
HFS-W7 Losing control 0.81 0.16 0.73 W-11
HFS-W8 No one to help during hypoglycemia 0.85 0.35 0.63 W-7
HFS-W9 Having hypoglycemia while driving 0.79 20.21 0.94 W-6
HFS-W10 Making mistakes or having accidents 0.85 20.28 1.04 W-9†
HFS-W11 Getting bad evaluation 0.72 0.06 0.7 W-16
HFS-W12 Difﬁculty thinking clearly 0.73 20.01 0.75 W-9†
HFS-W13 Feeling lightheaded or dizzy 0.61 0.18 0.51 W-12
HFS-W14 Injuring myself or others 0.81 20.11 0.9 W-13
HFS-W15 Permanent injury to health 0.74 20.15 0.86 W-8
HFS-W16 Low BG interfering with important things 0.73 0.08 0.71 W-3
HFS-W17 Becoming hypoglycemic while sleeping 0.63 0.17 0.53 W-1
HFS-W18 Becoming upset and difﬁcult 0.68 0.18 0.58 W-10
*PCMrankingofthemeasuresisonascalefrom1(themostfrequentlystronglyendorseditemoneachscale)tothehighestnumberoneachscalerepresentingtheleast
frequently strongly endorsed item. †Some rankings indicate tied measures.
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Hypoglycemia Fear Survey-IIacross a broad range of self-report instru-
ments.Constructvaliditywasadditionally
supported by the positive correlations
between the HFS-II and other valid mea-
sures of psychological distress, including
anxiety and depression. As expected,
higher HFS-II scores were negatively re-
lated to quality of life, with the HFS-W
subscale more strongly related to mental
and emotional quality of life and the HFS-
B subscale more strongly related to phys-
ical quality of life.
Overall, psychometric properties were
very good. Factor analyses supported a
two-factor solution over a one-factor so-
lution, with item loadings justifying the
structure and separate scoring of the HFS-
Band HFS-W subscales.A recent Swedish
study (24) found a three-factor solution
for the HFS-I in type 1diabetic patients,
with the third factor comprising HFS-W
items describing worries about being
alone during hypoglycemia. The current
study tested a three-factor solution for
the HFS-II but did not replicate the Swed-
ish ﬁndings. The three-factor solution for
the HFS-II did provide slightly better ﬁt,
but the third factor comprised a few items
ontheHFS-B,nottheHFS-W, subscale.It
is almost always the case that increasing
the number of factors results in better ﬁt,
althoughthisdoesnotnecessarilyresultin
better understanding of a scale. Unfortu-
nately, the HFS-B subscale was not in-
cluded in some of the datasets analyzed
for this study. Additional analysis of data-
sets with more HFS-B data are needed to
determine whether this factor will be con-
ﬁrmed and whether it improves the utility
of the HFS-II.
Rasch PCM analyses indicated very
good results for the items in the two HFS-
II subscales. Both subscales had excellent
separation, reasonable item-to-person
matching, and good item-ﬁt statistics,
indicating that they are appropriate mea-
sures of the constructs represented in the
two-factor solution. Two items on the
HFS-B (reduce insulin when BG is low
and measure BG six or more times per
day) yielded very low factor loadings,and
the Rasch PCM analysis indicated that
these items were, on average, the most
frequently strongly endorsed. Although
sometimesthistypeofresultmayindicate
appropriate removal of these items from
the instrument, this is not recommended
for two reasons. The ﬁrst is clinical sig-
niﬁcance. IRT analysis indicated that
these items tended to be strongly en-
dorsedbymostindividuals;therefore,the
failure to strongly endorse these items
may be important information to have
about a person’s behavioral reactions to
low BG levels. Second, maintaining these
items, and keeping the HFS-II consistent
across studies and translations, allows re-
searchers to compare results more easily
across various populations, translations,
and research.
It also is important to consider the
clinical implications of these ﬁndings.
The mean scores and comparisons across
different patient populations generated
by this study may help to guide clinical
interpretations of HFS-II scores. For ex-
ample, higher HFS-II scores, on both
subscales but especially on the HFS-W
subscale, are expected in patients with a
recenthistoryofseverehypoglycemia.On
the other hand, patients in poorer gly-
cemiccontroldidnotexhibithigherHFS-
W subscale scores but did exhibit higher
HFS-Bscores.Inaddition,whereasHFS-W
scores weremorestronglyrelatedtolower
quality of life in terms of emotional
distress, HFS-B scores were more
strongly related to lower quality of life
in terms of physical burden and impair-
ment. The original purpose of the two
subscale construction of the HFS was to
assessboththebehavioralandtheaffective
dimensions of patient experience and re-
action to hypoglycemia. These results
suggest that the instrument accomplishes
this goal. These results also support the
need to administer the entire HFS-II scale
in order to assess these different dimen-
sions of FOH and not just the HFS-W
subscale, which has been done in some
studies.
I ts t i l li sp r e m a t u r e ,h o w e v e r ,t o
generalize these ﬁndings to translated
versions of the HFS-II, and it is a limita-
tion of this study that only U.S. subjects
were included. Additional research is
needed to validate other versions of the
scale and to compare FOH across dif-
ferent cultures and countries. Other lim-
itations of this study include the
substantially lower number of HFS-B
surveys for analysis and the exclusion of
individuals with type 2 diabetes, which
w a sb e y o n dt h es c o p eo ft h i sa r t i c l e .
Future studies are needed of the psycho-
metric properties of the HFS-II in type 2
diabetes, as well as in pediatric patients
andtheirparents.Nonetheless,theresults
of this ﬁrst study indicate that the U.S.
English version of the HFS-II is a psycho-
metrically valid and reliable instrument
for adults with type 1 diabetes, with
potential clinical as well as scientiﬁc
utility for the assessment of FOH.
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